Jumonji domain containing protein 6: A novel oxygen sensor in the human placenta

Endocrinology (United States)

Volumn 156, Issue 8, 2015, Pages 3012-3025

  Alahari, Sruthi ^a,b   Post, Martin ^b,c,d   Caniggia, Isabella ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEMETHYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; JUMONJI DOMAIN CONTAINING PROTEIN 6; NITROPRUSSIDE SODIUM; OXYGEN; SUMO 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN; BIOLOGICAL MARKER; HIF1A PROTEIN, HUMAN; JMJD6 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL HYPOXIA; CELL ISOLATION; CELLULAR DISTRIBUTION; CHORIOCARCINOMA CELL LINE; CHORION VILLUS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; OXYGEN SENSING; OXYGEN TENSION; PLACENTA; PLACENTA FUNCTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; SYNCYTIOTROPHOBLAST; TROPHOBLAST; UBIQUITINATION; ANOXIA; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECTS; GENETICS; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; ONSET AGE; PATHOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY;

AGE OF ONSET; ANOXIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GESTATIONAL AGE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; OXIDATIVE STRESS; OXYGEN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 84938723240     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1262     Document Type: Article

References (52)

1. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science. 1997;277:1669-1672.
2. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol. 1992;80:283-285.
3. Caniggia I, Mostachfi H, Winter J, et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ (3). J Clin Invest. 2000;105: 577-587.
4. Ietta F, Wu Y, Winter J, et al. Dynamic HIF1A regulation during human placental development. Biol Reprod. 2006;75:112-121.
5. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447-5454.
6. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510 -5514.
7. Rajakumar A, Conrad KP. Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod. 2000;63:559-569.
8. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1γ in hypoxiamediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394:485-490.
9. Soleymanlou N, Jurisicova A, Wu Y, et al. Hypoxic switch in mitochondrial myeloid cell leukemia factor-1/Mtd apoptotic rheostat contributes to human trophoblast cell death in preeclampsia. Am J Pathol. 2007;171:496-506.
10. Caniggia I, Winter JL. Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies-a review. Placenta. 2002;23(suppl A):S47-S57.
11. Rajakumar A, Brandon HM, Daftary A, Ness R, Conrad KP. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta. 2004;25: 763-769.
12. Redman CW, Sargent IL. Placental debris, oxidative stress and preeclampsia. Placenta. 2000;21:597-602.
13. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43-54.
14. Koivunen P, Hirsilä M, Günzler V, Kivirikko KI, Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem. 2004;279:9899-9904.
15. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002;16:1466-1471.
16. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271-275.
17. Tsukada Y, Fang J, Erdjument-Bromage H, et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2006;439:811-816.
18. Klose RJ, Kallin EM, Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet. 2006;7:715-727.
19. Beyer S, Kristensen MM, Jensen KS, Johansen JV, Staller P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J Biol Chem. 2008;283: 36542-36552.
20. Chang B, Chen Y, Zhao Y, Bruick RK. JMJD6 is a histone arginine demethylase. Science. 2007;318:444-447.
21. Hewitson KS, McNeill LA, Riordan MV, et al. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem. 2002;277:26351-26355.
22. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev. 2000;14:1983-1991.
23. Webby CJ, Wolf A, Gromak N, et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science. 2009;325:90-93.
24. Wang F, He L, Huangyang P, et al. JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation. PLoS Biol. 2014;12:e1001819.
25. Cikala M, Alexandrova O, David CN, et al. The phosphatidylserine receptor from Hydra is a nuclear protein with potential Fe(II) dependent oxygenase activity. BMC Cell Biol. 2004;5:26.
26. Rolfo A, Many A, Racano A, et al. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One. 2010;5:e13288.
27. American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122: 1122-1131.
28. Sivasubramaniyam T, Garcia J, Tagliaferro A, et al. Where polarity meets fusion: role of Par6 in trophoblast differentiation during placental development and preeclampsia. Endocrinology. 2013;154: 1296-1309.
29. MacPhee DJ, Mostachfi H, Han R, Lye SJ, Post M, Caniggia I. Focal adhesion kinase is a key mediator of human trophoblast development. Lab Invest. 2001;81:1469-1483.
30. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGF-β 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest. 1999;103: 1641-1650.
31. Rahman S, Sowa ME, Ottinger M, et al. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol. 2011; 31:2641-2652.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods. 2001;25:402-408.
33. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999;222:222-235.
34. Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet. 1999;354:788-789.
35. Soleymanlou N, Jurisica I, Nevo O, et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab. 2005; 90:4299-4308.
36. Mantri M, Loik ND, Hamed RB, Claridge TD, McCullagh JS, Schofield CJ. The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues. Chembiochem. 2011;12:531-534.
37. Unoki M, Masuda A, Dohmae N, et al. Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6). J Biol Chem. 2013;288:6053-6062.
38. Murad S, Pinnell SR. Suppression of fibroblast proliferation and lysyl hydroxylase activity by minoxidil. J Biol Chem. 1987;262: 11973-11978.
39. Murad S, Walker LC, Tajima S, Pinnell SR. Minimum structural requirements for minoxidil inhibition of lysyl hydroxylase in cultured fibroblasts. Arch Biochem Biophys. 1994;308:42-47.
40. Wang J, Maldonado MA. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol. 2006;3:255-261.
41. Goldberg AL. Development of proteasome inhibitors as research tools and cancer drugs. J Cell Biol. 2012;199:583-588.
42. Clague MJ, Urbé S. Ubiquitin: same molecule, different degradation pathways. Cell. 2010;143:682-685.
43. Cai Q, Robertson ES. Ubiquitin/SUMO modification regulatesVHL protein stability and nucleocytoplasmic localization. PLoS One. 2010;5.
44. Cai Q, Verma SC, Kumar P, Ma M, Robertson ES. Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. PLoS One. 2010;5:e9720.
45. Cowden Dahl KD, Fryer BH, Mack FA, et al. Hypoxia-inducible factors 1γ and 2γ regulate trophoblast differentiation. Mol Cell Biol. 2005;25:10479-10491.
46. Hahn P, Wegner I, Burrells A, et al. Analysis of Jmjd6 cellular localization and testing for its involvement in histone demethylation. PLoS One. 2010;5:e13769.
47. Mekhail K, Gunaratnam L, Bonicalzi ME, Lee S. HIF activation by pH-dependent nucleolar sequestration of VHL. Nat Cell Biol. 2004; 6:642-647.
48. Berra E, Benizri E, Ginouv?s A, Volmat V, Roux D, Pouysségur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1γ in normoxia.EMBOJ. 2003;22:4082-4090.
49. Liu Z, Diaz LA, Haas AL, Giudice GJ. cDNA cloning of a novel human ubiquitin carrier protein. An antigenic domain specifically recognized by endemic pemphigus foliaceus autoantibodies is encoded in a secondary reading frame of this human epidermal transcript. J Biol Chem. 1992;267:15829-15835.
50. Jung CR, Hwang KS, Yoo J, et al. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med. 2006;12:809-816.
51. Hautala T, Heikkinen J, Kivirikko KI, Myllyla R. Minoxidil specifically decreases the expression of lysine hydroxylase in cultured human skin fibroblasts. Biochem J. 1992;283(pt 1):51-54.
52. Pan Y, Mansfield KD, Bertozzi CC, et al. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol. 2007;27:912-925.